WHO swine flu review committee promises to probe links with drug industryBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3648 (Published 07 July 2010) Cite this as: BMJ 2010;341:c3648
- John Zarocostas
The chairman of the external expert review committee examining the World Health Organization’s management of the H1N1 pandemic said on 2 July that the panel will probe deeper into allegations that the drug industry may have unduly influenced key outcomes.
Speaking at the end of the second round of hearings at WHO headquarters Harvey Fineberg, the head of the 27 member review committee, told reporters that, “Part of [our] concern is dealing with the accusations of undue influence by pharmaceutical companies on the decisions.”
Asked if that included looking into …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial